Two strategies aimed at preventing cardiovascular events in high-risk patients -- use of an angiotensin receptor blocker or a short-acting insulin secretagogue for five years -- failed to reduce myocardial infarction or stroke, researchers here reported...Now they tell you.
Nathan concluded that, for now, "we should steer away from these two drugs and use effective lifestyle interventions and, in selected persons, metformin to combat the epidemic."
Still think they have any idea what they are doing?
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.